191 related articles for article (PubMed ID: 37186134)
21. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
Wilson BG; Helming KC; Wang X; Kim Y; Vazquez F; Jagani Z; Hahn WC; Roberts CW
Mol Cell Biol; 2014 Mar; 34(6):1136-44. PubMed ID: 24421395
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
Li H; Yang F; Hu A; Wang X; Fang E; Chen Y; Li D; Song H; Wang J; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
EMBO Mol Med; 2019 Dec; 11(12):e10835. PubMed ID: 31709724
[TBL] [Abstract][Full Text] [Related]
24. Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.
Bellini A; Bessoltane-Bentahar N; Bhalshankar J; Clement N; Raynal V; Baulande S; Bernard V; Danzon A; Chicard M; Colmet-Daage L; Pierron G; Le Roux L; Planchon JM; Combaret V; Lapouble E; Corradini N; Thebaud E; Gambart M; Valteau-Couanet D; Michon J; Louis-Brennetot C; Janoueix-Lerosey I; Defachelles AS; Bourdeaut F; Delattre O; Schleiermacher G
Int J Cancer; 2019 Nov; 145(10):2781-2791. PubMed ID: 31018240
[TBL] [Abstract][Full Text] [Related]
25. A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex.
Hah N; Kolkman A; Ruhl DD; Pijnappel WW; Heck AJ; Timmers HT; Kraus WL
Cancer Res; 2010 Jun; 70(11):4402-11. PubMed ID: 20460533
[TBL] [Abstract][Full Text] [Related]
26. SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer.
Kim SY; Shen Q; Son K; Kim HS; Yang HD; Na MJ; Shin E; Yu S; Kang K; You JS; Yu KR; Jeong SM; Lee EK; Ahn YM; Park WS; Nam SW
Oncogene; 2021 Jul; 40(28):4652-4662. PubMed ID: 34140644
[TBL] [Abstract][Full Text] [Related]
27. Extracellular matrix-regulated gene expression requires cooperation of SWI/SNF and transcription factors.
Xu R; Spencer VA; Bissell MJ
J Biol Chem; 2007 May; 282(20):14992-9. PubMed ID: 17387179
[TBL] [Abstract][Full Text] [Related]
28. Exploring the Interaction between the SWI/SNF Chromatin Remodeling Complex and the Zinc Finger Factor CTCF.
Valletta M; Russo R; Baglivo I; Russo V; Ragucci S; Sandomenico A; Iaccarino E; Ruvo M; De Feis I; Angelini C; Iachettini S; Biroccio A; Pedone PV; Chambery A
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255744
[TBL] [Abstract][Full Text] [Related]
29. SWI/SNF complex-deficient soft tissue neoplasms: An update.
Schaefer IM; Hornick JL
Semin Diagn Pathol; 2021 May; 38(3):222-231. PubMed ID: 32646614
[TBL] [Abstract][Full Text] [Related]
30. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.
Pottier N; Yang W; Assem M; Panetta JC; Pei D; Paugh SW; Cheng C; Den Boer ML; Relling MV; Pieters R; Evans WE; Cheok MH
J Natl Cancer Inst; 2008 Dec; 100(24):1792-803. PubMed ID: 19066270
[TBL] [Abstract][Full Text] [Related]
31. The transcription of the main gene associated with Treacher-Collins syndrome (TCOF1) is regulated by G-quadruplexes and cellular nucleic acid binding protein (CNBP).
Gil Rosas M; Centola C; Torres M; Mouguelar VS; David AP; Piga EJ; Gomez D; Calcaterra NB; Armas P; Coux G
Sci Rep; 2024 Mar; 14(1):7472. PubMed ID: 38553547
[TBL] [Abstract][Full Text] [Related]
32. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
[TBL] [Abstract][Full Text] [Related]
33. BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways.
Jubierre L; Soriano A; Planells-Ferrer L; París-Coderch L; Tenbaum SP; Romero OA; Moubarak RS; Almazán-Moga A; Molist C; Roma J; Navarro S; Noguera R; Sánchez-Céspedes M; Comella JX; Palmer HG; Sánchez de Toledo J; Gallego S; Segura MF
Oncogene; 2016 Sep; 35(39):5179-90. PubMed ID: 26996667
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic studies for the role of cellular nucleic-acid-binding protein (CNBP) in regulation of c-myc transcription.
Chen S; Su L; Qiu J; Xiao N; Lin J; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta; 2013 Oct; 1830(10):4769-77. PubMed ID: 23774591
[TBL] [Abstract][Full Text] [Related]
35. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity.
Wang X; Guo Y; Chen G; Fang E; Wang J; Li Q; Li D; Hu A; Bao B; Zhou Y; Gao H; Song J; Du X; Zheng L; Tong Q
Oncogene; 2023 Sep; 42(36):2673-2687. PubMed ID: 37537343
[TBL] [Abstract][Full Text] [Related]
37. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.
Naito T; Udagawa H; Umemura S; Sakai T; Zenke Y; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuboi M; Ishii G; Goto K
Lung Cancer; 2019 Dec; 138():35-42. PubMed ID: 31630044
[TBL] [Abstract][Full Text] [Related]
38. SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.
Tessier-Cloutier B; Coatham M; Carey M; Nelson GS; Hamilton S; Lum A; Soslow RA; Stewart CJ; Postovit LM; Köbel M; Lee CH
J Pathol Clin Res; 2021 Mar; 7(2):144-153. PubMed ID: 33125840
[TBL] [Abstract][Full Text] [Related]
39. SWI/SNF protein component BAF250a regulates cardiac progenitor cell differentiation by modulating chromatin accessibility during second heart field development.
Lei I; Gao X; Sham MH; Wang Z
J Biol Chem; 2012 Jul; 287(29):24255-62. PubMed ID: 22621927
[TBL] [Abstract][Full Text] [Related]
40.
Concepcion CP; Ma S; LaFave LM; Bhutkar A; Liu M; DeAngelo LP; Kim JY; Del Priore I; Schoenfeld AJ; Miller M; Kartha VK; Westcott PMK; Sánchez-Rivera FJ; Meli K; Gupta M; Bronson RT; Riely GJ; Rekhtman N; Rudin CM; Kim CF; Regev A; Buenrostro JD; Jacks T
Cancer Discov; 2022 Feb; 12(2):562-585. PubMed ID: 34561242
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
